Skip to content


  • Research article
  • Open Access

Involvement of TIP60 acetyltransferase in intracellular Salmonellareplication

BMC Microbiology201010:228

  • Received: 11 May 2010
  • Accepted: 26 August 2010
  • Published:



Salmonella enterica is a facultative intracellular pathogen that replicates within a membrane-bound compartment termed Salmonella containing vacuole (SCV). The biogenesis of SCV requires Salmonella type III protein secretion/translocation system and their effector proteins which are translocated into host cells to exploit the vesicle trafficking pathways. SseF is one of these effectors required for SCV formation and Intracellular Salmonella replication through unknown mechanisms.


In an attempt to identify host proteins that interact with SseF, we conduct a yeast two-hybrid screening of human cell cDNA library using SseF as the bait. We identified that TIP60, an acetyltransferase, interacts with SseF. We showed that the TIP60 acetylation activity was increased in the presence of SseF, and TIP60 was upregulated upon Salmonella infection. In addition, TIP60 is required for efficient intracellular Salmonella replication in macrophages.


Taken together, our data suggest that Salmonella may use SseF to exploit the host TIP60 acetyltransferase activity to promote efficient Salmonella replication inside host cells.


  • Histone Acetylation
  • Sodium Butyrate
  • Acetylation Activity
  • GAL4 Binding Domain
  • TIP60 Interaction


Protein acetylation adds the acetyl group on either the amino-terminal residues or on the epsilon-amino group of lysine residues. Lysine acetylation affects many protein functions, including DNA binding, protein-protein interactions, and protein stability. TIP60 catalyzes histone acetylation [1, 2]. It was originally identified as a cellular acetyltransferase protein that interacts with HIV-1 Tat [3]. Over-expression of TIP60 increased Tat transactivation of the HIV-1 promoter [3]. Recent studies found that TIP60 has diverse functions involved in transcription, cellular signaling, DNA damage repair, cell cycle checkpoint control and apoptosis [2, 4, 5].

Salmonella enterica serovar Typhimurium (S. typhimurium) causes gastrointestinal diseases in humans and typhoid-like fever in the mouse. S. typhimurium encodes two Type III secretion systems within the Salmonella pathogenicity islands 1 and 2 (SPI-1 and SPI-2) that are required for Salmonella entry and subsequent survival inside the host cells, respectively [610]. Following entry into the host cells, S. typhimurium replicates within a membrane-bound compartment termed S almonella-containing vacuole (SCV). Previous studies have shown that SifA, SseF and SseG are involved in the formation of S almonella induced filaments (Sifs) that are required for maintaining the SCV [1113].

SseF, working together with SseG, has been shown to be involved in the aggregation of host endosomes and may help to position the Salmonella-containing vacuoles in close association with the Golgi network [1419]. In the absence of SseF, the vacuolar compartments containing Salmonella were discontinuous and intracellular Salmonella replication was reduced [10, 14, 15, 2022]. SseG was shown to be co-localized with the trans-Golgi network and only bacteria closely associated with the Golgi network were able to multiply [11]. It has been shown that SseF interacts functionally and physically with SseG but not SifA and is also required for the perinuclear localization of Salmonella vacuoles [23]. The molecular mechanism on how SseF and SseG function remains unknown. In the present study, we set out to search the host target that interacts with SseF. We presented evidence indicating that Salmonella SseF interacts with TIP60 to potentiate its histone acetylation activity to promote intracellular replication.


Bacterial strains

Bacterial strains and plasmids used in this study are listed in Table 1. Chromosomal gene replacements were carried out by using a suicide plasmid [24, 25]. E. coli and S. typhimurium strains are routinely cultured in Luria-Bertani broth (LB). Salmonella trains were grown in MgM minimal medium when SPI-2 TTSS-inducing conditions were desired [26]. Antibiotics used were: ampicillin at 120 μg/ml, streptomycin at 25 μg/ml, and tetracycline at 12 μg/ml.
Table 1

Bacterial strains and plasmids

Strains and plasmids

Relevant Characteristics


S. typhimurium and E. coli


Wild-type S. typhimurium, Strr



SseF in-frame deletions

This study

SM10 λpir

thi thr leu tonA lacY supE recA::RP4-2-Tc::Mu (Kanr) λpir




SsaV in-frame deletions in pSB890; Tcr



SseF in-frame deletions in pSB890; Tcr



SseFΔ67-106, 161-174, 186-205 in pGBT9, Apr

This study


His-SseF in pET28a; Kanr

This study


His-SseG in pET28a; Kanr

This study


GAL4AD-iTIP60164-546 in pGAD-GH; Apr

This study


GAL4AD-TIP60α in pGAD-GH; Apr

This study


GAL4AD-TIP60β in pGAD-GH; Apr

This study


HA-TIP60α in pcDNA3; Apr

This study


MBP-TIP60α in pIADL16; Apr

This study


GAL4-BD-SseF1-66 in pGBT9; Apr

This study


GAL4-BD-SseF50-66 in pGBT9; Apr

This study


GST-SseF1-66 in pGEX-KG; Apr

This study


GST-SseF50-66 in pGEX-KG; Apr

This study


GAL4-BD-SseF1-56 in pGBT9; Apr

This study


GAL4-BD-SseF50-260 in pGBT9; Apr

This study


GAL4-BD-SseF1-228 in pGBT9; Apr

This study

Mammalian cell lines and bacterial infection assay

The murine macrophage RAW264.7 (TIB-71, ATCC) and the human epithelial cell line HeLa (CCL-2, ATCC) were from the ATCC (Manassas, VA) and were maintained in Dulbecco's modified Eagle medium (DMEM) containing 10% FBS. Bacterial infection of RAW264.7 and survival assays were carried out using opsonized bacteria in DMEM containing 10% normal mouse serum as described before [10, 20, 27]. The extent of replication was then determined by dividing the number of intracellular bacteria at twenty-four hours by the number at two hours.

Yeast Two-hybrid Screening

The GAL4-based yeast two-hybrid system was used following standard procedures [28]. The bait plasmid (pZP784) was constructed by deleting the putative three trans-membrane regions (67-106, 161-174, 186-205 a.a.) of SseF and fusing it to the yeast GAL4 binding domain in pGBT9.m [28]. A human cell cDNA library was constructed by oligo(dT) priming in pACT2 (Clontech Laboratories, Palo Alto, CA). A total of 5 × 105 transformants were screened in the yeast indicator strain AH109, using the sequential transformation protocol as described (Clontech Laboratories). Clones that grow on the yeast synthetic drop-out media lacking histidine and exhibited positive galactosidase on the X-Gal plates were chosen for further analysis.

Protein purification and biochemical pull down assay

GST, His and MBP-tagged recombinant proteins were expressed and purified in Escherichia coli BL21 (DE3) using the pGEX-KG, pET28a, or the pMAL-c2x expression systems, respectively. The purification of the GST-tagged proteins was performed according to the manufacturer's instructions (Amersham, Pittsburgh, PA). Purified proteins were concentrated and buffer exchanged in PBS, using a 10 K and 30 K molecular weight cut-off dialysis cassette (Sartorius, Elk Grove, IL). Purified proteins were snap-frozen in liquid nitrogen and stored at -80°C in PBS/20% glycerol. Proteins were pre-clarified at 120,000 Xg, and their concentration was determined by Bradford assay (Bio-Rad) using bovine serum albumin as standard. Pulled-down proteins were analyzed by SDS-PAGE and Western blotting using appropriate antibodies. Western blots were developed with using the SuperSignal West Pico detection reagent according to the manufacturer's instructions (Thermo Fisher, Rockford, IL).

HAT Assay

HAT assays were performed using recombinant MBP-TIP60 protein (100 ng) as acetyltransferase and histone (2 μg, Sigma, St. Louis, MO) as the substrate in 20 μl HAT buffer (50 mM Tris, pH 8.0, 10% glycerol, 1 mM dithiothreitol, 0.1 mM EDTA, 10 mM sodium butyrate) containing Acetyl-CoA (100 μM, Sigma, St. Louis, MO) for 30 min at 30°C. Acetylated histones were detected by Western blot, using the pan-acetyl antibody (Santa Cruz Biotech, Santa Cruz, CA).


TIP60 siRNA expression plasmids were constructed in pSilencer 2.1 (Ambion, Austin, TX) with a pair of 63-bp oligonucleotides, each containing a unique 19-bp TIP60 sequence. For use in human cell lines: 5'-GATCCGAACAAGAGTTAATTCCCAGTTC AAGAGACTGGGAATAACTCTTGTTCTTTTTTGGAAA-3' and 5'-AGCTTTTCCAAAAAA GAACAAGAGTTATTCCCAGTCTCTTGAACTGGGAATAACTCTTGTTCG-3'. For use in mouse cell lines: 5'-GATCCAGACTGGAGCAAGAGAGGATTCAAGAGATCCTCTCTTGC TCCAGTCTTTTTTTGGAAA-3' and 5'-AGCTTTTCCAAAAAAAGACTGGAGCAAGAG AGGATCTCTTGAATCCTCTCTTGCTCCAGTCTG-3'. For negative control, a scrambled siRNA hairpin was placed into the same sites in pSilencer 2.1. These plasmids were transfected into cells using the siPORT XP-1 provided by Ambion. Transfected cells were maintained for 24 hours without selection; cultures were then subjected to G418 selection before infection.


SalmonellaSPI2 effector protein SseF interacts with TIP60 histone acetylase

In a search for host proteins that interact with SseF, we conducted a yeast two-hybrid screening [29] of a human cell cDNA library, using a fusion of the DNA-binding domain of GAL4 and the truncated SseF devoid of transmembrane regions (pZP784, SseFΔ67-106, 161-174, 186-205) as the bait. One clone was identified which encodes the C-terminal 164-546 TIP60 histone acetyltransferase isoform 1 (Fig. 1). There are at least three splice variants of TIP60: TIP60 isoform 1 (iTIP60), TIP60 isoform 2 (TIP60α), and TIP60 isoform 3 (TIP60β). iTIP60 retains the alternatively spliced intron 1 [30]. TIP60β lacks exon 5 [31]. Different isoforms potentially involve distinct functions in the cells. When tested in the yeast two-hybrid, all three TIP60 isoforms interacted with GAL4BD-SseF chimerical protein (Fig. 1). To determine the region of SseF that is responsible for interacting with TIP60, a series of SseF deletions was constructed and tested in the yeast two-hybrid for their ability to interact with TIP60. We found that amino acids 50-66 were sufficient for mediating the SseF and TIP60 interaction (Fig. 1). We observed weak interactions occasionally when confirming the interactions biochemically using purified recombinant proteins. This is not unusual as most wild-type enzymes do not interact strongly with their target molecules. It is also possible that the three putative transmembrane regions in SseF are essential for tight interactions and the fragment devoid of the transmembrane regions has reduced affinity rendering it difficult to detecting the interactions in vitro.
Figure 1
Figure 1

Interaction of SseF with TIP60. (A) Plasmids expressing the SseF devoid of putative transmembrane regions fused to the GAL4 binding domain were transformed into yeast strain AH109 expressing a fusion between the GAL4 activation domain and iTIP60164-546 (pZF1). (B) Plasmids expressing the various SseF fragments fused to the GAL4 binding domain were transformed into yeast strain AH109 expressing a fusion between the GAL4 activation domain and different TIP60 isoforms. SipA together with Plastin was used as a positive control. Yeast strains expressing the above plasmid combinations were streaked on SD-Leu-Trp (-LW) or -Leu-Trp-His+15 mM 3-AT media (-LWH). Quantitative β-galactosidase activities were measured from yeast grown in SD-Leu-Trp and expressed in Miller units.

SseF increases the histone acetylation activity of TIP60

TIP60 is a multifunctional acetyltransferase involved in many transcriptional regulations by serving as a co-regulator [5]. The interaction of SseF with TIP60 suggested that SseF may serve as the substrate for TIP60-mediated acetylation. To test whether SseF serves as the substrate for TIP60, an in vitro HAT assay was conducted, using purified recombinant MBP-TIP60 as acetyltransferase and GST-SseF1-66 as the substrate [2, 4, 5]. When probed with antibodies specific for acetylated species, adducts were detected when histone was added to the reaction in the presence of MBP-TIP60 (data not shown). No SseF acetylation was observed when GST-SseF1-66 was used in the reaction. Similar results were obtained when partially enriched full-length SseF was used in the reaction (data not shown). Thus, SseF is not likely the substrate for TIP60.

Since SseF is not likely the substrate for TIP60, we explored the possibility that SseF-TIP60 interaction may alter the acetylation activity of TIP60 without direct modification. We then examined whether GST-SseF1-66 affected TIP60-mediated histone acetylation, using the in vitro HAT assay with recombinant MBP-TIP60 as the acetyltransferase and histone as the substrate in the presence of GST-SseF1-66 or GST. We observed an increase in the amount of acetylated histone H2, H3 and H4 when GST-SseF1-66 was added to the reaction while addition of GST had no obvious effect (Fig. 2A). The increase is more pronounced for the histone isoform H2 and more moderate for isoforms H3 and H4 (Fig. 2A) [2]. We next explored whether the full-length SseF has similar effect as the GST-SseF1-66 to histone acetylation. We previously showed that SscB is the chaperone for SseF and that they interact with each other [20]. We obtained SseF-M45 by co-expressing SseF and SscB followed by pulling down His-SscB. The enriched SseF-M45 was then used in the in vitro HAT assay as described above. Again, we observed increased TIP60-mediated Histone H2 acetylation in the presence of SseF-M45 (Fig. 2A). Similar enhancement of TIP60-mediated histone H2 acetylation was noted when enriched His-SseF was used in the HAT assay (Fig. 2B). No obvious change in TIP60-mediated histone acetylation was found when His-SseG was used in the same reaction (Fig. 2B). Taken together, we conclude that SseF can potentiate the Histone H2 acetylation activity of TIP60.
Figure 2
Figure 2

SseF increases the histone acetylation activity of TIP60. HAT assays were performed using recombinant MBP-TIP60 protein as acetyltransferase and histone as the substrate in the presence of (A) GST-SseF1-66, SseF-M45, GST, or (B) His-SseF, His-SseG. Acetylated histones were detected by Western blot using the pan-acetyl antibody. Total amounts of proteins were examined by Western blot using anti-GST, -M45, or His antibodies, respectively. * Indicate acetylated histone isoform H2.

TIP60 protein level is increased upon Salmonellainfection

TIP60 is known to be involved in diverse functions and the endogenous basal level of TIP60 is usually low. TIP60 level increases significantly upon UV irradiation [32]. Upon Salmonella infection of HeLa cells, we observed an increase in TIP60 as short as 60 minutes after infection and approaching maximum induction three hours post infection (Fig. 3). Actin levels in the same samples remained constant up to 4 hours after infection. This supports the notion that TIP60 might play an important role during Salmonella infection. This increase is SseF-independent, as similar increase was also observed when infected with an sseF mutant Salmonella strain and TIP60 was not concentrated at the vacuoles (data not shown). SseF was not detected in infected cells possibly due to the low amounts translocated during Salmonella infections.
Figure 3
Figure 3

TIP60 is up regulated upon Salmonella infection. HeLa cells were infected with wild-type Salmonella for the indicated time intervals. Infected cell lysates were subjected to SDS-PAGE followed by Western blot using anti-TIP60 antibody (upper panel). Actin levels in the same samples were also determined as a control (lower panel).

TIP60 is required for efficient intracellular Salmonellareplication

Previous studies have shown that SseF is required for efficient intracellular Salmonella replication in macrophages [10]. Since TIP60 acetyltransferase interacts with SseF, TIP60 might be required for efficient intracellular Salmonella replication. To test this, we used siRNA to down-regulate the endogenous level of TIP60. Macrophages were transfected with a plasmid expressing TIP60 siRNA or a control vector expressing the scrambled siRNA. As shown in Fig. 4, TIP60 siRNA effectively suppressed the endogenous TIP60 expression, while the control siRNA did not. Transfected macrophages were infected with wild-type S. typhimurium or the sseF mutant strains. As shown in Fig. 4, down-regulation of TIP60 leads to less efficient Salmonella replication comparable to the level of sseF mutant strain [10]. There was not significant replication change in cells expressing the scrambled siRNA. These data support our notion that TIP60 is required for efficient intracellular Salmonella replication in macrophages.
Figure 4
Figure 4

TIP60 is required for efficient Salmonella replication. Transfected macrophages were infected with wild-type S. typhimurium or the sseF mutant strains at an MOI of 10. Extracellular bacteria were removed by washing and gentamicin treatment. At 2 and 24 h after bacterial invasion, cells were lysed, and the number of intracellular bacteria was enumerated. The data shown were obtained from three independent experiments with standard errors. The effect of TIP60 knockdown is verified by Western blot using the anti-TIP60 antibodies. Actin was used a control.


We do not know yet the molecular mechanism of how SseF and TIP60 interaction affects the SCV and intracellular Salmonella replication. Ideally, a mutant SseF lacking the TIP60-binding domain can be used to assess the requirement for SseF-TIP60 interaction for its function, however such a mutant is defective in secretion and thus not translocated, making it impossible to assess its effect during infection. Definitive identification of the acetylation site and subsequent characterization of proper mutants lacking TIP60-mediated acetylation will be required to validate this hypothesis. Alternatively, SseF-TIP60 interaction may alter the acetylation activity of TIP60, thus affecting TIP60 related functions. Supporting this hypothesis, our preliminary in vitro acetylation assays suggest that SseF increased the histone acetylation activity of TIP60, especially for histone H2. Histone is the only known substrate for Tip60. Total histone acetylation was not increased in infected cells (data not shown). This is consistent with the low amount of SseF translocated. It is possible that local SseF concentration may be higher in infected cells.

Although TIP60 is not known to be directly involved in vesicle trafficking, it is possible that TIP60 affected histone acetylation leading to altered expression of trafficking-related proteins. Interestingly, our preliminary data showed that knock down of TIP60 reduced continuous Sif formation, a phenotype similar to that of the sseF null mutant (Additional file 1: Fig. S1). Future experiments are required to determine whether the increase in histone acetylation leads to increases in TIP60-mediated downstream functions. This may ultimately help us to understand how SseF interact with TIP60 to promote Salmonella replication inside the host cells.


We found that TIP60, an acetyltransferase, interacts with Salmonella SseF. We further showed that the TIP60 acetylation activity was increased in the presence of SseF, and TIP60 was upregulated upon Salmonella infection. More importantly, TIP60 is required for efficient intracellular Salmonella replication in macrophages. Our study demonstrated that Salmonella may use SseF to exploit the host TIP60 acetyltransferase activity to promote efficient Salmonella replication inside host cells.



Research was supported by NSFC grant 30628001 to D. Z., and by "863" grant 2006AA02A253 to D.Q.

Authors’ Affiliations

Department of Molecular Virology, Shanghai Medical College of Fudan University, Shanghai, 200032, P.R. China
Department of Biological Sciences, Purdue University, West Lafayette, IN 47907, USA


  1. Utley RT, Cote J: The MYST family of histone acetyltransferases. Curr Top Microbiol Immunol. 2003, 274: 203-236.PubMedGoogle Scholar
  2. Ikura T, Ogryzko VV, Grigoriev M, Groisman R, Wang J, Horikoshi M, Scully R, Qin J, Nakatani Y: Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis. Cell. 2000, 102 (4): 463-473. 10.1016/S0092-8674(00)00051-9.View ArticlePubMedGoogle Scholar
  3. Kamine J, Elangovan B, Subramanian T, Coleman D, Chinnadurai G: Identification of a cellular protein that specifically interacts with the essential cysteine region of the HIV-1 Tat transactivator. Virology. 1996, 216 (2): 357-366. 10.1006/viro.1996.0071.View ArticlePubMedGoogle Scholar
  4. Kim MY, Ann EJ, Kim JY, Mo JS, Park JH, Kim SY, Seo MS, Park HS: Tip60 histone acetyltransferase acts as a negative regulator of notch1 signaling by means of acetylation. Mol Cell Biol. 2007, 27 (18): 6506-6519. 10.1128/MCB.01515-06.PubMed CentralView ArticlePubMedGoogle Scholar
  5. Sapountzi V, Logan IR, Robson CN: Cellular functions of TIP60. Int J Biochem Cell Biol. 2006, 38 (9): 1496-1509. 10.1016/j.biocel.2006.03.003.View ArticlePubMedGoogle Scholar
  6. Shea JE, Beuzon CR, Gleeson C, Mundy R, Holden DW: Influence of the Salmonella typhimurium pathogenicity island 2 type III secretion system on bacterial growth in the mouse. Infect Immun. 1999, 67 (1): 213-219.PubMed CentralPubMedGoogle Scholar
  7. Hensel M, Shea JE, Raupach B, Monack D, Falkow S, Gleeson C, Kubo T, Holden DW: Functional analysis of ssaJ and the ssaK/U operon, 13 genes encoding components of the type III secretion apparatus of Salmonella Pathogenicity Island 2. Mol Microbiol. 1997, 24 (1): 155-167. 10.1046/j.1365-2958.1997.3271699.x.View ArticlePubMedGoogle Scholar
  8. Vazquez-Torres A, Xu Y, Jones-Carson J, Holden DW, Lucia SM, Dinauer MC, Mastroeni P, Fang FC: Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase. Science. 2000, 287 (5458): 1655-1658. 10.1126/science.287.5458.1655.View ArticlePubMedGoogle Scholar
  9. Galán JE, Curtiss R: Cloning and molecular characterization of genes whose products allow Salmonella typhimurium to penetrate tissue culture cells. Proc Natl Acad Sci USA. 1989, 86 (16): 6383-6387. 10.1073/pnas.86.16.6383.PubMed CentralView ArticlePubMedGoogle Scholar
  10. Hensel M, Shea JE, Waterman SR, Mundy R, Nikolaus T, Banks G, Vazquez-Torres A, Gleeson C, Fang FC, Holden DW: Genes encoding putative effector proteins of the type III secretion system of Salmonella pathogenicity island 2 are required for bacterial virulence and proliferation in macrophages. Mol Microbiol. 1998, 30 (1): 163-174. 10.1046/j.1365-2958.1998.01047.x.View ArticlePubMedGoogle Scholar
  11. Salcedo SP, Holden DW: SseG, a virulence protein that targets Salmonella to the Golgi network. EMBO J. 2003, 22 (19): 5003-5014. 10.1093/emboj/cdg517.PubMed CentralView ArticlePubMedGoogle Scholar
  12. Boucrot E, Henry T, Borg JP, Gorvel JP, Meresse S: The intracellular fate of Salmonella depends on the recruitment of kinesin. Science. 2005, 308 (5725): 1174-1178. 10.1126/science.1110225.View ArticlePubMedGoogle Scholar
  13. Abrahams GL, Hensel M: Manipulating cellular transport and immune responses: dynamic interactions between intracellular Salmonella enterica and its host cells. Cell Microbiol. 2006, 8 (5): 728-737. 10.1111/j.1462-5822.2006.00706.x.View ArticlePubMedGoogle Scholar
  14. Guy RL, Gonias LA, Stein MA: Aggregation of host endosomes by Salmonella requires SPI2 translocation of SseFG and involves SpvR and the fms-aroE intragenic region. Mol Microbiol. 2000, 37 (6): 1417-1435. 10.1046/j.1365-2958.2000.02092.x.View ArticlePubMedGoogle Scholar
  15. Hansen-Wester I, Stecher B, Hensel M: Type III secretion of Salmonella enterica serovar Typhimurium translocated effectors and SseFG. Infect Immun. 2002, 70 (3): 1403-1409. 10.1128/IAI.70.3.1403-1409.2002.PubMed CentralView ArticlePubMedGoogle Scholar
  16. Kuhle V, Hensel M: SseF and SseG are translocated effectors of the type III secretion system of Salmonella pathogenicity island 2 that modulate aggregation of endosomal compartments. Cell Microbiol. 2002, 4 (12): 813-824. 10.1046/j.1462-5822.2002.00234.x.View ArticlePubMedGoogle Scholar
  17. Kuhle V, Jackel D, Hensel M: Effector proteins encoded by Salmonella pathogenicity island 2 interfere with the microtubule cytoskeleton after translocation into host cells. Traffic. 2004, 5 (5): 356-370. 10.1111/j.1398-9219.2004.00179.x.View ArticlePubMedGoogle Scholar
  18. Abrahams GL, Muller P, Hensel M: Functional dissection of SseF, a type III effector protein involved in positioning the salmonella-containing vacuole. Traffic. 2006, 7 (8): 950-965. 10.1111/j.1600-0854.2006.00454.x.View ArticlePubMedGoogle Scholar
  19. Ramsden AE, Mota LJ, Munter S, Shorte SL, Holden DW: The SPI-2 type III secretion system restricts motility of Salmonella-containing vacuoles. Cell Microbiol. 2007, 9 (10): 2517-2529. 10.1111/j.1462-5822.2007.00977.x.PubMed CentralView ArticlePubMedGoogle Scholar
  20. Dai S, Zhou D: Secretion and function of Salmonella SPI-2 effector SseF require its chaperone, SscB. J Bacteriol. 2004, 186 (15): 5078-5086. 10.1128/JB.186.15.5078-5086.2004.PubMed CentralView ArticlePubMedGoogle Scholar
  21. Freeman JA, Ohl ME, Miller SI: The Salmonella enterica serovar Typhimurium translocated effectors SseJ and SifB are targeted to the Salmonella-containing vacuole. Infect Immun. 2003, 71 (1): 418-427. 10.1128/IAI.71.1.418-427.2003.PubMed CentralView ArticlePubMedGoogle Scholar
  22. Hensel M: Salmonella pathogenicity island 2. Mol Microbiol. 2000, 36 (5): 1015-1023. 10.1046/j.1365-2958.2000.01935.x.View ArticlePubMedGoogle Scholar
  23. Deiwick J, Salcedo SP, Boucrot E, Gilliland SM, Henry T, Petermann N, Waterman SR, Gorvel JP, Holden DW, Meresse S: The translocated Salmonella effector proteins SseF and SseG interact and are required to establish an intracellular replication niche. Infect Immun. 2006, 74 (12): 6965-6972. 10.1128/IAI.00648-06.PubMed CentralView ArticlePubMedGoogle Scholar
  24. Chang J, Chen J, Zhou D: Delineation and characterization of the actin nucleation and effector translocation activities of Salmonella SipC. Mol Microbiol. 2005, 55 (5): 1379-1389. 10.1111/j.1365-2958.2004.04480.x.View ArticlePubMedGoogle Scholar
  25. Kaniga K, Delor I, Cornelis GR: A wide-host-range suicide vector for improving reverse genetics in Gram-negative bacteria: inactivation of the blaA gene of Yersinia enterocolitica. Gene. 1991, 109: 137-141. 10.1016/0378-1119(91)90599-7.View ArticlePubMedGoogle Scholar
  26. Deiwick J, Nikolaus T, Erdogan S, Hensel M: Environmental regulation of Salmonella pathogenicity island 2 gene expression. Mol Microbiol. 1999, 31 (6): 1759-1773. 10.1046/j.1365-2958.1999.01312.x.View ArticlePubMedGoogle Scholar
  27. De Groote MA, Ochsner UA, Shiloh MU, Nathan C, McCord JM, Dinauer MC, Libby SJ, Vazquez-Torres A, Xu Y, Fang FC: Periplasmic superoxide dismutase protects Salmonella from products of phagocyte NADPH-oxidase and nitric oxide synthase. Proc Natl Acad Sci USA. 1997, 94 (25): 13997-14001. 10.1073/pnas.94.25.13997.PubMed CentralView ArticlePubMedGoogle Scholar
  28. Bartel PL, Fields S: Analyzing protein-protein interactions using two-hybrid system. Methods Enzymol. 1995, 254: 241-263. full_text.View ArticlePubMedGoogle Scholar
  29. Fields S, Song O: A novel genetic system to detect protein-protein interactions. Nature. 1989, 340: 245-246. 10.1038/340245a0.View ArticlePubMedGoogle Scholar
  30. Legube G, Trouche D: Identification of a larger form of the histone acetyl transferase Tip60. Gene. 2003, 310: 161-168. 10.1016/S0378-1119(03)00547-X.View ArticlePubMedGoogle Scholar
  31. Ran Q, Pereira-Smith OM: Identification of an alternatively spliced form of the Tat interactive protein (Tip60), Tip60(beta). Gene. 2000, 258 (1-2): 141-146. 10.1016/S0378-1119(00)00410-8.View ArticlePubMedGoogle Scholar
  32. Legube G, Linares LK, Lemercier C, Scheffner M, Khochbin S, Trouche D: Tip60 is targeted to proteasome-mediated degradation by Mdm2 and accumulates after UV irradiation. EMBO J. 2002, 21 (7): 1704-1712. 10.1093/emboj/21.7.1704.PubMed CentralView ArticlePubMedGoogle Scholar
  33. Hoiseth SK, Stocker BA: Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature. 1981, 291: 238-239. 10.1038/291238a0.View ArticlePubMedGoogle Scholar
  34. Miller VL, Mekalanos JJ: A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J Bacteriol. 1988, 170: 2575-2583.PubMed CentralPubMedGoogle Scholar


© Wang et al; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.